Diabetes Care, 0149-5992


  1. 2020
  2. Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Ouwens, D. M., Hartmann, B., Holst, J. J., Touw, D. J., Danser, A. H. J., Joles, J. A., & van Raalte, D. H. (2020). Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial. Diabetes Care, 43(10), 2889-2893. https://doi.org/10.2337/dc20-0902
  3. 2019
  4. ASIAN-HF Investigators, Tromp, J., Lim, S. L., Tay, W. T., Teng, T-H. K., Chandramouli, C., Ouwerkerk, W., Wander, G. S., Sawhney, J. P. S., Yap, J., MacDonald, M. R., Ling, L. H., Sattar, N., McMurray, J. J. V., Richards, A. M., Anand, I., & Lam, C. S. P. (2019). Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction. Diabetes Care, 42(9), 1792-1799. https://doi.org/10.2337/dc18-2515
  5. Vloemans, A. F., Eilander, M. M. A., Rotteveel, J., Bakker-van Waarde, W. M., Houdijk, E. C. A. M., Nuboer, R., Winterdijk, P., Snoek, F. J., & De Wit, M. (2019). Youth With Type 1 Diabetes Taking Responsibility for Self-Management: The Importance of Executive Functioning in Achieving Glycemic Control: Results From the Longitudinal DINO Study. Diabetes Care, 42(2), 225-231. https://doi.org/10.2337/dc18-1143
  6. Clegg, L. E., Heerspink, H. J. L., Penland, R. C., Tang, W., Boulton, D. W., Bachina, S., Fox, R. D., Fenici, P., Thuresson, M., Mentz, R. J., Hernandez, A. F., & Holman, R. R. (2019). Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL. Diabetes Care, 42(2), 318-326. https://doi.org/10.2337/dc18-1871
  7. 2018
  8. Ozcan, B., Rutters, F., Snoek, F. J., Roosendaal, M., Sijbrands, E. J., Elders, P. J. M., Holleman, F., Pijl, H., Tack, C. J., Abbink, E. J., de Valk, H. W., Wolffenbuttel, B. H. R., Stehouwer, C. D. A., Schaper, N. C., Dekker, J. M., Schram, M. T., & Diabet Peart Parelsnoer Initiative (2018). High Diabetes Distress Among Ethnic Minorities Is Not Explained by Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch Diabetes Pearl Cohort. Diabetes Care, 41(9), 1854-1861. https://doi.org/10.2337/dc17-2181
  9. BEAt-DKD Consortium, Heinzel, A., Kammer, M., Mayer, G., Reindl-Schwaighofer, R., Hu, K., Perco, P., Eder, S., Rosivall, L., Mark, P. B., Ju, W., Kretzler, M., Gilmour, P., Wilson, J. M., Duffin, K. L., Abdalla, M., McCarthy, M. I., Heinze, G., Heerspink, H. L., ... Oberbauer, R. (2018). Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes. Diabetes Care, 41(9), 1947-1954. https://doi.org/10.2337/dc18-0532
  10. Yamamoto, J. M., Kellett, J. E., Balsells, M., Garcia-Patterson, A., Hadar, E., Sola, I., Gich, I., van der Beek, E. M., Castaneda-Gutierrez, E., Heinonen, S., Hod, M., Laitinen, K., Olsen, S. F., Poston, L., Rueda, R., Rust, P., van Lieshout, L., Schelkle, B., Murphy, H. R., & Corcoy, R. (2018). Gestational Diabetes Mellitus and Diet: A Systematic Review and Meta-analysis of Randomized Controlled Trials Examining the Impact of Modified Dietary Interventions on Maternal Glucose Control and Neonatal Birth Weight. Diabetes Care, 41(7), 1346-1361. https://doi.org/10.2337/dc18-0102
  11. Oosterom, N., Gant, C. M., Ruiterkamp, N., van Beijnum, B-J. F., Hermens, H., Bakker, S. J. L., Navis, G., Vollenbroek-Hutten, M. M. R., & Laverman, G. D. (2018). Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care. Diabetes Care, 41(4), E50-E51. https://doi.org/10.2337/dc17-2041
  12. 2017
  13. Mayer, G., Heerspink, H. J. L., Aschauer, C., Heinzel, A., Heinze, G., Kainz, A., Sunzenauer, J., Perco, P., de Zeeuw, D., Rossing, P., Pena, M., Oberbauer, R., & SYSKID Consortium (2017). Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes. Diabetes Care, 40(3), 391-397. https://doi.org/10.2337/dc16-2202
  14. 2016
  15. 2015
  16. Lotta, L. A., Abbasi, A., Sharp, S. J., Sahlqvist, A-S., Waterworth, D., Brosnan, J. M., Scott, R. A., Langenberg, C., & Wareham, N. J. (2015). Definitions of Metabolic Health and Risk of Future Type 2 Diabetes in BMI Categories: A Systematic Review and Network Meta-analysis. Diabetes Care, 38(11), 2177-2187. https://doi.org/10.2337/dc15-1218
  17. Gutierrez-Achury, J., Romanos, J., Bakker, S. F., Magadi Gopalaiah, V. K., de Haas, E. C., Trynka, G., Ricano-Ponce, I., Steck, A., Chen, W-M., Onengut-Gumuscu, S., Simsek, S., Rewers, M., Mulder, C. J., Liu, E., Rich, S. S., Wijmenga, C., & Type 1 Diabet Genetics Consortium (2015). Contrasting the Genetic Background of Type 1 Diabetes and Celiac Disease Autoimmunity. Diabetes Care, 38, S37-S44. https://doi.org/10.2337/dcs15-2007
  18. Signore, A., Capriotti, G., Chianelli, M., Bonanno, E., Galli, F., Catalano, C., Quintero, A. M., De Toma, G., Manfrini, S., Pozzilli, P., & Action LADA Grp (2015). Detection of Insulitis by Pancreatic Scintigraphy With Tc-99m-Labeled IL-2 and MRI in Patients With LADA (Action LADA 10). Diabetes Care, 38(4), 652-658. https://doi.org/10.2337/dc14-0580
  19. Neal, B., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Fulcher, G., Ways, K., Desai, M., Shaw, W., Capuano, G., Alba, M., Jiang, J., Vercruysse, F., Meininger, G., Matthews, D., & CANVAS Trial Collaborative Grp (2015). Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes. Diabetes Care, 38(3), 403-411. https://doi.org/10.2337/dc14-1237
  20. 2014
  21. Diamant, M., Nauck, M. A., Shaginian, R., Malone, J. K., Cleall, S., Reaney, M., de Vries, D., Hoogwerf, B. J., MacConell, L., Wolffenbuttel, B. H. R., & 4B Study Grp (2014). Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes. Diabetes Care, 37(10), 2763-2773. https://doi.org/10.2337/dc14-0876
  22. Goedendorp, M. M., Tack, C. J., Steggink, E., Bloot, L., Bazelmans, E., & Knoop, H. (2014). Chronic fatigue in type 1 diabetes. Diabetes Care, 37(1), 73-80. https://doi.org/10.2337/dc13-0515
  23. 2013
  24. Wolffenbuttel, B. H. R., Herman, W. H., Gross, J. L., Dharmalingam, M., Jiang, H. H., & Hardin, D. S. (2013). Ethnic differences in glycemic markers in patients with type 2 diabetes. Diabetes Care, 36(10), 2931-2936. https://doi.org/10.2337/dc12-2711
  25. Jørgensen, M. E., Borch-Johnsen, K., Stolk, R., & Bjerregaard, P. (2013). Fat distribution and glucose intolerance among Greenland Inuit. Diabetes Care, 36(10), 2988-2994. https://doi.org/10.2337/dc12-2703
  26. 2012
  27. Morton, J., Zoungas, S., Li, Q., Patel, A. A., Chalmers, J., Woodward, M., Celermajer, D. S., Beulens, J. W. J., Stolk, R. P., Glasziou, P., Ng, M. K. C., & ADVANCE Collaborative Grp (2012). Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy Results of the ADVANCE study. Diabetes Care, 35(11), 2201-2206. https://doi.org/10.2337/dc12-0306
  28. de Mol, P., Fokkert, M. J., de Vries, S. T., de Koning, E. J. P., Dikkeschei, B. D., Gans, R. O. B., Tack, C. J., & Bilo, H. J. G. (2012). Metabolic Effects of High Altitude Trekking in Patients With Type 2 Diabetes. Diabetes Care, 35(10), 2018-2020. https://doi.org/10.2337/dc12-0204
  29. Alssema, M., Newson, R. S., Bakker, S. J. L., Stehouwer, C. D. A., Heymans, M. W., Nijpels, G., Hillege, H. L., Hofman, A., Witteman, J. C. M., Gansevoort, R. T., & Dekker, J. M. (2012). One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease. Diabetes Care, 35(4), 741-748. https://doi.org/10.2337/dc11-1417
Previous 1 2 3 Next

ID: 778209